Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Carisma Therapeutics (Nasdaq: CARM), a clinical-stage biopharmaceutical company specializing in immunotherapies, announced its participation in the 7th Annual Evercore ISI HealthCONx Conference. Steven Kelly, President and CEO, will engage in a fireside chat on December 5th at 9:35 am ET. The event will be accessible via audio webcast on the company's Investor Relations webpage under the Investor Events section, with -time archive availability.

PHILADELPHIA, Nov. 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the 7^th Annual Evercore ISI HealthCONx Conference on Thursday, December 5^th at 9:35 am ET.

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-7th-annual-evercore-isi-healthconx-conference-302316979.html

SOURCE Carisma Therapeutics Inc.

FAQ

When is Carisma Therapeutics (CARM) presenting at the Evercore ISI HealthCONx Conference 2024?

Carisma Therapeutics will present at the Evercore ISI HealthCONx Conference on Thursday, December 5th, 2024, at 9:35 am ET.

How can investors watch Carisma Therapeutics' (CARM) presentation at the HealthCONx Conference?

Investors can watch the presentation via audio webcast available on Carisma Therapeutics' Investor Relations webpage under the Investor Events section.

Who will represent Carisma Therapeutics (CARM) at the 2024 Evercore ISI HealthCONx Conference?

Steven Kelly, President and Chief Executive Officer of Carisma Therapeutics, will represent the company in a fireside chat at the conference.

What type of presentation will Carisma Therapeutics (CARM) give at the HealthCONx Conference?

Carisma Therapeutics will participate in a fireside chat format presentation at the conference.